Healthcare Services Industry Financials, Performance and Ratios
-
Industry Score
46.1 /100
Rank 63 out of 131 Industries -
Advance/Decline
40/12
-
No. of Companies52
-
Avg. Market Cap2,243
-
Price to Earning Ratio26.20
-
Price to Earning Growth Ratio13.82
-
Price to Book Ratio8.37
-
Return on Equity30.97
-
Return on Capital Employed-
-
Return on Assets6.39
-
Dividend yield 1 year %0.43 %
-
Net Profit Growth Annual YoY %73.59 %
-
Net Profit Growth Qtr YoY %170.43 %
-
Net Profit Growth Qtr QoQ %115.86 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Healthcare Services Industry Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Healthcare Services Peer comparison
Compare all stocks in Healthcare Services industry listed on stock exchanges
| Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Agilon Health Inc |
|
418.7
|
1.0
|
L
 6.3%
H
0.9
1.0
|
L
 4.1%
H
0.9
1.1
|
L
 36.5%
H
0.7
1.1
|
L
 7.5%
H
0.5
1.1
|
L
 -70.4%
H
0.5
6.1
|
L
 -95.1%
H
0.5
29.4
|
L
H
0.5
44.8
|
L
H
0.5
44.8
|
| Concord Medical Services (ADR) |
|
20.0
|
4.6
|
L
 8.2%
H
4.1
5.4
|
L
 11.1%
H
3.8
5.4
|
L
 10.8%
H
3.6
5.7
|
L
 -13.0%
H
3.5
6.0
|
L
 -0.2%
H
3.5
10.8
|
L
 -68.3%
H
3.5
26.7
|
L
 -87.6%
H
3.5
47
|
L
 -89.5%
H
3.5
58.9
|
| Ginkgo Bioworks Holdings Inc (Class A) |
|
648.3
|
10.7
|
L
 9.4%
H
9.9
11.1
|
L
 8.6%
H
8.6
11.1
|
L
 32.1%
H
8.1
11.1
|
L
 -18.5%
H
7.4
13.8
|
L
 -7.6%
H
5
17.6
|
L
 544.6%
H
0.2
17.6
|
L
H
0.2
17.6
|
L
H
0.2
17.6
|
| DaVita |
|
7,707.4
|
109.2
|
L
 2.7%
H
107.2
110.4
|
L
 5.1%
H
102.3
110.4
|
L
 -5.2%
H
101
117.4
|
L
 -15.0%
H
101
130.8
|
L
 -35.8%
H
101
179.6
|
L
 35.9%
H
71.5
179.6
|
L
 -8.5%
H
65.3
179.6
|
L
 67.4%
H
43.4
179.6
|
| Enhabit Inc |
|
560.2
|
11.1
|
L
 3.1%
H
11.0
11.4
|
L
 2.5%
H
10.4
11.4
|
L
 15.8%
H
8.9
11.4
|
L
 30.2%
H
7.6
11.4
|
L
 38.6%
H
6.5
11.4
|
L
 -28.0%
H
6.5
16.6
|
L
H
6.5
25.3
|
L
H
6.5
25.3
|
| Encompass Health Corp |
|
9,998.2
|
99.4
|
L
 0.0%
H
98.5
100.4
|
L
 -0.9%
H
98.5
103.5
|
L
 -6.6%
H
98.2
108.6
|
L
 -20.4%
H
98.2
128.0
|
L
 3.7%
H
92.5
128.0
|
L
 58.5%
H
51.2
128.0
|
L
 42.8%
H
42.2
128.0
|
L
 265.6%
H
24.1
128.0
|
| Fresenius Medical Care AG & Co. KGaA (ADR) |
|
12,944.7
|
22.3
|
L
 3%
H
21.7
22.5
|
L
 4.4%
H
20.9
22.5
|
L
 -5.0%
H
20.9
24.1
|
L
 -17.7%
H
20.9
27.4
|
L
 -3.3%
H
20.9
30.5
|
L
 21.9%
H
16.4
30.5
|
L
 -46.6%
H
12.8
42.5
|
L
 -44.4%
H
12.8
57.9
|
| Hims & Hers Health Inc (Class A) |
|
6,947.8
|
30.5
|
L
 5.6%
H
29
30.8
|
L
 -2.6%
H
28.0
31.8
|
L
 -14.2%
H
28.0
36.5
|
L
 -38.2%
H
28.0
51.0
|
L
 2.4%
H
24.0
73.0
|
L
 320.4%
H
5.7
73.0
|
L
 97.8%
H
2.7
73.0
|
L
H
2.7
73.0
|
| Pediatrix Medical Grp Inc |
|
1,907.3
|
22.2
|
L
 0.6%
H
21.9
22.5
|
L
 0.9%
H
21.6
22.8
|
L
 1.4%
H
21.0
22.8
|
L
 31.4%
H
16.8
25.0
|
L
 58.6%
H
11.8
25.0
|
L
 46.1%
H
6.6
25.0
|
L
 -9.3%
H
6.6
35.7
|
L
 -67.1%
H
6.6
77.0
|
| Sonida Senior Living Inc |
|
595.9
|
31.8
|
L
 -0.8%
H
31.6
32.4
|
L
 0.4%
H
31.3
32.4
|
L
 -3.6%
H
30.8
33.1
|
L
 21.9%
H
24.9
33.5
|
L
 36.4%
H
19.3
33.5
|
L
 106.2%
H
6
34.3
|
L
 25.7%
H
6
55.2
|
L
 -86.2%
H
6
292.8
|
| Teladoc Health Inc |
|
1,127.0
|
6.4
|
L
 3.1%
H
6.2
6.4
|
L
 -3.9%
H
6.0
6.7
|
L
 -12.2%
H
6.0
8.1
|
L
 -26.7%
H
6.0
9.8
|
L
 -33.2%
H
6.0
15.2
|
L
 -75.7%
H
6.0
34.4
|
L
 -97.4%
H
6.0
308
|
L
 -61.1%
H
6.0
308
|
| U.S. Physical Therapy Inc |
|
1,329.9
|
87.5
|
L
 1.7%
H
86.3
88.7
|
L
 1.8%
H
84.1
88.9
|
L
 12.3%
H
76.8
88.9
|
L
 -2.4%
H
66.7
93.5
|
L
 -2.9%
H
62.8
93.5
|
L
 -7.2%
H
62.8
124.1
|
L
 -31.4%
H
62.8
143.7
|
L
 86.5%
H
45.1
148.5
|
| Acadia Healthcare Co Inc |
|
1,370.2
|
15.2
|
L
 5.7%
H
13.8
15.8
|
L
 29.2%
H
11.4
15.8
|
L
 5.1%
H
11.4
15.8
|
L
 -35.6%
H
11.4
24.1
|
L
 -65.9%
H
11.4
45.6
|
L
 -82.1%
H
11.4
87.8
|
L
 -70.6%
H
11.4
89.9
|
L
 -74.1%
H
11.1
89.9
|
| Addus HomeCare Corp |
|
2,040.0
|
110.4
|
L
 0.6%
H
108.8
112.0
|
L
 -0.1%
H
106.5
112.0
|
L
 -2.2%
H
105.2
113.9
|
L
 -9.2%
H
105.2
124.4
|
L
 -18.8%
H
89.0
136.7
|
L
 0.7%
H
77.3
136.7
|
L
 -11.3%
H
68.6
136.7
|
L
 460.0%
H
15.3
136.7
|
| Aveanna Healthcare Holdings Inc |
|
1,863.5
|
8.9
|
L
 -0.8%
H
8.9
9.1
|
L
 -4.5%
H
8.7
9.8
|
L
 -1.9%
H
7.7
9.8
|
L
 -12.8%
H
7.7
10
|
L
 80.2%
H
3.7
10.3
|
L
 669.0%
H
0.9
10.3
|
L
H
0.7
13
|
L
H
0.7
13
|
| Azenta Inc |
|
1,886.0
|
41.0
|
L
 1.6%
H
40.4
41.7
|
L
 3.8%
H
38.5
41.7
|
L
 19.1%
H
32.9
41.7
|
L
 28.9%
H
28.8
41.7
|
L
 -23.8%
H
23.9
55.6
|
L
 -26.4%
H
23.9
69.2
|
L
 -51.3%
H
23.9
124.8
|
L
 352.6%
H
8.3
124.8
|
| Biodesix Inc |
|
88.3
|
11.1
|
L
 1.7%
H
10.5
11.4
|
L
 29.2%
H
7.7
11.9
|
L
 65.9%
H
5.3
11.9
|
L
 62.5%
H
5.3
11.9
|
L
 -48.1%
H
3.4
22.8
|
L
 -76.8%
H
3.4
50.6
|
L
 -98.1%
H
3.4
586.5
|
L
H
3.4
639.8
|
| Burning Rock Biotech Ltd (ADR) |
|
442.1
|
41.1
|
L
 32.2%
H
30.0
41.7
|
L
 44.0%
H
29
41.7
|
L
 89.2%
H
19.1
41.7
|
L
 304.5%
H
10
41.7
|
L
 502.9%
H
2.2
41.7
|
L
 22.2%
H
2.2
41.7
|
L
 -88.9%
H
2.2
397.5
|
L
H
2.2
397.5
|
| Celldex Therapeutics Inc |
|
1,784.2
|
26.9
|
L
 2.6%
H
25.7
27.0
|
L
 1.9%
H
25
27.0
|
L
 4.9%
H
25
28.3
|
L
 -3.8%
H
22.1
30.5
|
L
 9.1%
H
14.4
30.5
|
L
 -42.4%
H
14.4
53.2
|
L
 49.7%
H
14.4
57.2
|
L
 -84.3%
H
1.5
178.8
|
| DocGo Inc |
|
83.1
|
0.9
|
L
H
0.8
0.9
|
L
 -4.5%
H
0.8
0.9
|
L
 -4.5%
H
0.8
1.0
|
L
 -43.0%
H
0.8
1.5
|
L
 -80.3%
H
0.8
5.7
|
L
 -90.6%
H
0.8
10.8
|
L
 -92.0%
H
0.8
11.9
|
L
H
0.8
11.9
|
| Dyadic Intl Inc, DE |
|
32.9
|
0.9
|
L
 2.3%
H
0.9
1.0
|
L
 3.4%
H
0.9
1.0
|
L
 -9%
H
0.8
1.0
|
L
 -18.0%
H
0.8
1.3
|
L
 -41.7%
H
0.7
1.7
|
L
 -41.3%
H
0.7
2.7
|
L
 -83.9%
H
0.7
8.8
|
L
 -41.7%
H
0.7
11.0
|
| Ensign Grp Inc |
|
10,136.3
|
175.0
|
L
 -1.6%
H
174.6
179.4
|
L
 -1.5%
H
174.6
184.6
|
L
 -3.5%
H
172
184.6
|
L
 -4.5%
H
172
194
|
L
 25.6%
H
118.7
194
|
L
 87.8%
H
85.5
194
|
L
 110.2%
H
68.3
194
|
L
 796.5%
H
15.4
194
|
| Euda Health Holdings Ltd |
|
60.1
|
1.6
|
L
 -3.1%
H
1.5
1.8
|
L
 -16.8%
H
1.5
2.1
|
L
 -43.2%
H
1.2
3.0
|
L
 -49.7%
H
1.2
3.6
|
L
 -57.7%
H
1.0
4.5
|
L
 -7.6%
H
0.4
6.3
|
L
H
0.4
10.5
|
L
H
0.4
10.5
|
| Fulgent Genetics Inc |
|
870.8
|
28.2
|
L
 1.2%
H
28.0
28.9
|
L
 0.7%
H
27.5
29.0
|
L
 2.0%
H
25.1
29.0
|
L
 17.5%
H
22.1
31.0
|
L
 59.8%
H
14.6
31.0
|
L
 -13.7%
H
14.6
44.1
|
L
 -57.5%
H
14.6
189.9
|
L
H
2.9
189.9
|
| Guardant Health Inc |
|
15,231.7
|
117.3
|
L
 1.3%
H
116.0
120.7
|
L
 8.0%
H
108.4
120.7
|
L
 17.6%
H
97.3
120.7
|
L
 73.7%
H
66.6
120.7
|
L
 159.9%
H
34.9
120.7
|
L
 270.0%
H
15.8
120.7
|
L
 -27.6%
H
15.8
181.1
|
L
H
15.8
181.1
|
| Intelligent Bio Soln Inc |
|
11.8
|
9.7
|
L
 -1.5%
H
8.9
10.4
|
L
 -37.7%
H
8.9
15.8
|
L
 58.3%
H
4.0
24.9
|
L
 -8.3%
H
4.0
24.9
|
L
 -33.4%
H
4.0
27.5
|
L
 -98.5%
H
4.0
3840
|
L
 -99.9%
H
4.0
23112
|
L
H
4.0
34176
|
| Joint Corp |
|
148.2
|
10.0
|
L
 -1.1%
H
9.9
10.2
|
L
 -2.6%
H
9.6
10.7
|
L
 10.8%
H
8.6
10.7
|
L
 14.5%
H
7.5
10.7
|
L
 -12.5%
H
7.5
13.5
|
L
 -45.8%
H
7.3
19.5
|
L
 -66.4%
H
7.3
111.1
|
L
 132.4%
H
1.9
111.1
|
| LifeMD Inc |
|
174.3
|
3.6
|
L
 2.3%
H
3.6
3.7
|
L
 -6.0%
H
3.4
3.9
|
L
 12.1%
H
3.2
4.4
|
L
 -41.3%
H
3.2
6.4
|
L
 -30.0%
H
3.2
15.8
|
L
 103.4%
H
1.1
15.8
|
L
 -63.4%
H
1.1
33.0
|
L
 352.5%
H
0.4
33.0
|
| LifeStance Health Grp Inc |
|
2,866.9
|
7.4
|
L
 2.2%
H
7.2
7.5
|
L
 1.7%
H
7.0
7.5
|
L
 4.5%
H
6.8
7.5
|
L
 41.7%
H
4.8
7.5
|
L
 -7.9%
H
3.7
8.3
|
L
 41.5%
H
3.7
9.6
|
L
H
3.7
29.8
|
L
H
3.7
29.8
|
| Neogenomics Inc |
|
1,678.2
|
13.0
|
L
 2.2%
H
12.6
13.3
|
L
 -1.9%
H
12.3
13.3
|
L
 9.6%
H
11.4
13.7
|
L
 24.4%
H
9.4
13.7
|
L
 -8.5%
H
4.7
15.3
|
L
 16.0%
H
4.7
21.2
|
L
 -76.5%
H
4.7
61.6
|
L
 88.2%
H
4.7
61.6
|
| Nutex Health Inc |
|
1,127.4
|
159.4
|
L
 8.5%
H
148.0
170
|
L
 -3.9%
H
141.1
172.1
|
L
 -7.3%
H
141.1
193.1
|
L
 39.2%
H
94.5
193.1
|
L
 314.1%
H
36.1
193.1
|
L
 -21.3%
H
0.6
268.5
|
L
 -30.5%
H
0.6
7920
|
L
 -92.9%
H
0.6
30000
|
| Option Care Health Inc - Registered Shares |
|
5,808.0
|
36.6
|
L
 0.9%
H
35.8
36.7
|
L
 3.0%
H
35.2
36.7
|
L
 12.6%
H
30.9
36.7
|
L
 29.7%
H
24.2
36.7
|
L
 24.2%
H
24.2
36.7
|
L
 30.7%
H
21.4
36.7
|
L
 89.3%
H
16.0
36.7
|
L
 416.8%
H
3.9
36.7
|
| Opko Health Inc |
|
1,044.1
|
1.4
|
L
 -1.5%
H
1.4
1.4
|
L
 4.6%
H
1.3
1.4
|
L
 3.8%
H
1.2
1.4
|
L
 -8.1%
H
1.2
1.5
|
L
 -9.3%
H
1.1
2.0
|
L
 -8.7%
H
0.9
2.2
|
L
 -68.9%
H
0.9
6.3
|
L
 -82.6%
H
0.9
12.2
|
| Pennant Group Inc |
|
1,077.9
|
31.2
|
L
 3.9%
H
30.1
31.9
|
L
 8.1%
H
28.0
31.9
|
L
 6.2%
H
27.5
31.9
|
L
 29.7%
H
22.3
31.9
|
L
 11.6%
H
21.2
31.9
|
L
 158.2%
H
10.3
37.1
|
L
 -48.4%
H
8.7
64.3
|
L
H
6.2
69.6
|
| Precipio Inc |
|
42.7
|
24.4
|
L
 -1.3%
H
23.8
24.5
|
L
 1.6%
H
23.1
25.5
|
L
 9.9%
H
22.1
28.3
|
L
 12.5%
H
18.5
28.5
|
L
 266.1%
H
3.9
28.5
|
L
 48.7%
H
3.9
28.5
|
L
 -50.2%
H
3.9
183.6
|
L
 -99.6%
H
3.9
14308.2
|
| Personalis Inc |
|
999.0
|
11.3
|
L
 16.6%
H
9.7
11.5
|
L
 21.0%
H
9.0
11.5
|
L
 31.6%
H
7.7
11.5
|
L
 17.6%
H
6.6
11.5
|
L
 102.7%
H
2.8
11.5
|
L
 423.3%
H
0.9
11.5
|
L
 -77.0%
H
0.9
49.3
|
L
H
0.9
53.5
|
| Radnet Inc |
|
5,639.3
|
73.0
|
L
 1.4%
H
72.4
75.0
|
L
 0.1%
H
69.5
75.0
|
L
 -4.8%
H
69.5
81.2
|
L
 -9.0%
H
64.4
85.8
|
L
 21.2%
H
45
85.8
|
L
 253.9%
H
19.8
93.7
|
L
 265.2%
H
12.0
93.7
|
L
 1226.7%
H
4.7
93.7
|
| Sera Prognostics Inc (Class A) |
|
132.8
|
3.4
|
L
 -3.1%
H
3.4
3.6
|
L
 -2.8%
H
3.3
3.7
|
L
 -3.1%
H
2.8
3.9
|
L
 2.4%
H
2.3
4.0
|
L
 -48.2%
H
1.4
6.9
|
L
 126.3%
H
1.2
12.4
|
L
H
1.1
15.5
|
L
H
1.1
15.5
|
| Talkspace Inc |
|
657.7
|
4.0
|
L
 3.9%
H
3.8
4.1
|
L
 4.8%
H
3.7
4.1
|
L
 11.8%
H
3.5
4.1
|
L
 47.0%
H
2.6
4.1
|
L
 26.4%
H
2.2
4.4
|
L
 436.5%
H
0.6
4.4
|
L
 -65.7%
H
0.5
12.5
|
L
H
0.5
12.5
|
| Tenon Medical Inc |
|
10.8
|
1.0
|
L
 3.2%
H
0.9
1.0
|
L
H
0.9
1
|
L
 -11.8%
H
0.9
1.1
|
L
 -18.5%
H
0.9
1.3
|
L
 -45.5%
H
0.9
5.9
|
L
 -99.3%
H
0.9
219.2
|
L
H
0.9
4791.2
|
L
H
0.9
4791.2
|
| Oncology Institute Inc |
|
353.2
|
3.6
|
L
 6.5%
H
3.4
3.7
|
L
 7.2%
H
3.2
3.7
|
L
 2.6%
H
3.2
4.5
|
L
 -15.7%
H
2.9
4.9
|
L
 498.3%
H
0.6
4.9
|
L
 134.6%
H
0.1
4.9
|
L
H
0.1
12.7
|
L
H
0.1
12.7
|
| GeneDx Holdings Corp (Class A) |
|
2,944.8
|
101.9
|
L
 1.8%
H
100.7
106.9
|
L
 -2.6%
H
97.6
113.2
|
L
 -27.5%
H
97.6
144.0
|
L
 -16.3%
H
97.6
170.9
|
L
 37.0%
H
55.2
170.9
|
L
 685.5%
H
1.2
170.9
|
L
 -74.3%
H
1.2
896.9
|
L
H
1.2
896.9
|
| Exagen Inc |
|
110.8
|
4.9
|
L
 3.4%
H
4.7
5.1
|
L
 -3.9%
H
4.4
5.1
|
L
 -24.0%
H
4.4
6.8
|
L
 -58.2%
H
4.4
12.2
|
L
 22.0%
H
2.7
12.2
|
L
 71.0%
H
1.3
12.2
|
L
 -69.5%
H
1.3
24.7
|
L
H
1.3
29.9
|
| BrightSpring Health Services Inc |
|
7,142.0
|
39.6
|
L
 0.9%
H
39.3
40.9
|
L
 3.0%
H
38.2
40.9
|
L
 5.6%
H
36.9
41.0
|
L
 22.8%
H
30.6
41.0
|
L
 89.6%
H
15.5
41.0
|
L
 337.1%
H
7.9
41.0
|
L
 337.1%
H
7.9
41.0
|
L
 337.1%
H
7.9
41.0
|
| BrightSpring Health Services Inc - Unit |
|
-
|
135.4
|
L
 4.3%
H
135.4
135.4
|
L
 5.0%
H
127.6
135.4
|
L
 6.4%
H
126.2
137.1
|
L
 24.4%
H
105.9
137.1
|
L
 62.1%
H
80.8
137.1
|
L
 62.1%
H
80.8
137.1
|
L
 62.1%
H
80.8
137.1
|
L
 62.1%
H
80.8
137.1
|
| Autonomix Medical Inc |
|
3.2
|
0.5
|
L
 4.4%
H
0.4
0.5
|
L
 -11.3%
H
0.4
0.5
|
L
 -24.2%
H
0.4
0.9
|
L
 -57.7%
H
0.4
1.6
|
L
 -84.1%
H
0.4
3.3
|
L
H
0.4
152
|
L
H
0.4
152
|
L
H
0.4
152
|
| Auna S.A. - Ordinary Shares - Cls A |
|
418.9
|
5.7
|
L
 14.8%
H
5.0
5.7
|
L
 22.0%
H
4.5
5.7
|
L
 22.8%
H
4.5
5.7
|
L
 -11.0%
H
4.5
6.7
|
L
 -18.6%
H
4.5
7.2
|
L
 -18.6%
H
4.5
7.2
|
L
 -18.6%
H
4.5
7.2
|
L
 -18.6%
H
4.5
7.2
|
| BrightSpring Health Services Inc - Unit |
|
-
|
135.4
|
L
 4.3%
H
135.4
135.4
|
L
 5.0%
H
127.6
135.4
|
L
 6.4%
H
126.2
137.1
|
L
 24.4%
H
105.9
137.1
|
L
 58.6%
H
68.1
137.1
|
L
 58.6%
H
68.1
137.1
|
L
 58.6%
H
68.1
137.1
|
L
 58.6%
H
68.1
137.1
|
| Concentra Grp Holdings Parent Inc |
|
2,785.1
|
21.7
|
L
 -1.2%
H
21.6
22.2
|
L
 6.4%
H
20.3
22.2
|
L
 11.8%
H
19.1
22.2
|
L
 6.7%
H
18.5
22.2
|
L
 -2.6%
H
18.5
24.2
|
L
H
18.5
24.8
|
L
H
18.5
24.8
|
L
H
18.5
24.8
|
| Radiopharm Theranostics Ltd (ADR) |
|
39.8
|
5.1
|
L
 3.5%
H
4.9
5.1
|
L
 -2.9%
H
4.9
5.3
|
L
 -2.7%
H
4.7
5.8
|
L
 -16.7%
H
3.6
16.3
|
L
 21.7%
H
3.6
16.3
|
L
 21.7%
H
3.6
16.3
|
L
 21.7%
H
3.6
16.3
|
L
 21.7%
H
3.6
16.3
|
| Basel Medical Grp Ltd |
|
14.7
|
0.8
|
L
H
0.8
0.8
|
L
 -1.3%
H
0.7
0.9
|
L
 8.3%
H
0.5
0.9
|
L
 -51.9%
H
0.5
1.7
|
L
H
0.5
9.4
|
L
H
0.5
9.4
|
L
H
0.5
9.4
|
L
H
0.5
9.4
|
| Lumexa Imaging Holdings Inc |
|
1,390.1
|
14.7
|
L
 -2.8%
H
14.6
15.3
|
L
 -5.5%
H
14
16.0
|
L
 -17.1%
H
14
18.7
|
L
 -20.6%
H
14
19.5
|
L
 -20.6%
H
14
19.5
|
L
 -20.6%
H
14
19.5
|
L
 -20.6%
H
14
19.5
|
L
 -20.6%
H
14
19.5
|